{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:20:53Z","timestamp":1771878053872,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Backgrounds<\/jats:title>\n            <jats:p>People with metabolic dysfunction-associated steatotic liver disease (MASLD) frequently report fatigue. This symptom is associated with hepatic inflammation and fibrosis. FibroScan-aspartate aminotransferase (FAST) score is a noninvasive measurement tool that can be used to assess the severity of MASLD. We aimed to investigate the independent factors associated with patient-reported outcomes (PROs) including fatigue, and their FAST scores.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We enrolled 116 patients with MASLD. PROs were assessed by the Chronic Liver Disease Questionnaire for nonalcoholic fatty liver disease (CLDQ-NAFLD), which consists of six domains including fatigue. Each domain score that was less than 6 was classified into the impairment group. A cutoff value of 0.67 in the FAST score was used to categorize a high or low FAST score. Independent factors associated with impaired PROs and fatigue were analyzed using logistic regression analysis and a graphical model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>For factor total, in the logistic regression analysis, the high FAST score was only identified as a negative independent factor for impaired total CLDQ-NAFLD (odds ratio: 5.9, 95% confidence interval: 1.11\u201331.20, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.034). The graphical model revealed that FAST score, BMI, and age directly interact with impaired total CLDQ-NAFLD. For fatigue, there was no statistically significant factor in the logistic regression analysis. The graphical model revealed that the FAST score, BMI, estimated glomerular filtration rate, and age directly interact with fatigue.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We found that the FAST score directly interacted with total CLDQ-NAFLD and the domain of fatigue. The FAST score may be a useful tool to assess impaired CLDQ-NAFLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/meg.0000000000002895","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T21:01:11Z","timestamp":1733173271000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Fast score is associated with patient-reported outcomes in patients with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1097","volume":"37","author":[{"given":"Ryuki","family":"Hashida","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Kurume University School of Medicine, Kurume"},{"name":"Division of Rehabilitation, Kurume University Hospital, Fukuoka, Japan"},{"name":"The Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Nakano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsubasa","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Liver Center, Saga University Hospital, Saga, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Kurume University School of Medicine, Kurume"},{"name":"Division of Rehabilitation, Kurume University Hospital, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Matsuse","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Kurume University School of Medicine, Kurume"},{"name":"Division of Rehabilitation, Kurume University Hospital, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pegah","family":"Golabi","sequence":"additional","affiliation":[{"name":"The Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn H.","family":"Gerber","sequence":"additional","affiliation":[{"name":"The Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[{"name":"The Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA"},{"name":"The Global NASH Council, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Hiraoka","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Kurume University School of Medicine, Kurume"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"R1-20250430","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/hep.30125","article-title":"Patient-reported outcomes and the economic effects of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: the value proposition.","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"R2-20250430","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/liv.13391","article-title":"A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD.","volume":"37","author":"Younossi","year":"2017","journal-title":"Liver Int"},{"key":"R3-20250430","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jgh.15172","article-title":"Patient-reported outcomes in patients with non-alcoholic fatty liver disease: a narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis.","volume":"36","author":"Yamamura","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R4-20250430","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.cgh.2019.02.024","article-title":"Reduced patient-reported outcome scores associate with level of fibrosis in patients with nonalcoholic steatohepatitis.","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-20250430","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.cgh.2021.07.020","article-title":"Obeticholic acid impact on quality of life in patients with nonalcoholic steatohepatitis: REGENERATE 18-month interim analysis.","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-20250430","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R7-20250430","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/gutjnl-2022-328689","article-title":"Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis.","volume":"72","author":"Ravaioli","year":"2023","journal-title":"Gut"},{"key":"R8-20250430","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R9-20250430","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/hepr.12511","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis.","volume":"45","author":"Watanabe","year":"2015","journal-title":"Hepatol Res"},{"key":"R10-20250430","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"key":"R11-20250430","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/hepr.13453","article-title":"Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma.","volume":"50","author":"Hirota","year":"2020","journal-title":"Hepatol Res"},{"key":"R12-20250430","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.cgh.2019.01.001","article-title":"Validation of Chronic Liver Disease Questionnaire for nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic steatohepatitis.","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R13-20250430","first-page":"799","article-title":"Association between activity and brain-derived neurotrophic factor in patients with non-alcoholic fatty liver disease: a data-mining analysis.","volume":"11","author":"Hashida","year":"2021","journal-title":"Life (Basel)"},{"key":"R14-20250430","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/hepr.13481","article-title":"Controlled attenuation parameter by vibration-controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging-based proton density fat fraction.","volume":"50","author":"Zeng","year":"2020","journal-title":"Hepatol Res"},{"key":"R15-20250430","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12863-017-0561-z","article-title":"Network analysis for count data with excess zeros.","volume":"18","author":"Choi","year":"2017","journal-title":"BMC Genet"},{"key":"R16-20250430","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.cgh.2021.11.004","article-title":"Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: data from the global non-alcoholic steatohepatitis (NASH)\/non-alcoholic fatty liver disease (NAFLD) registry.","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-20250430","doi-asserted-by":"crossref","first-page":"e0266859","DOI":"10.1371\/journal.pone.0266859","article-title":"Validation of the accuracy of the FAST score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.","volume":"17","author":"Woreta","year":"2022","journal-title":"PLoS One"},{"key":"R18-20250430","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1007\/s10620-021-07363-x","article-title":"Validation and performance of FibroScan(R)-AST (FAST) score on a Brazilian population with nonalcoholic fatty liver disease.","volume":"67","author":"Cardoso","year":"2022","journal-title":"Dig Dis Sci"},{"key":"R19-20250430","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jceh.2021.06.008","article-title":"FibroScan-AST (FAST) score for nonalcoholic steatohepatitis - validation in an Indian cohort.","volume":"12","author":"De","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R20-20250430","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/liv.13919","article-title":"Fatigue in chronic liver disease: new insights and therapeutic approaches.","volume":"39","author":"Swain","year":"2019","journal-title":"Liver Int"},{"key":"R21-20250430","doi-asserted-by":"crossref","first-page":"e0152512","DOI":"10.1371\/journal.pone.0152512","article-title":"Differential sympathetic vasomotor activation induced by liver cirrhosis in rats.","volume":"11","author":"Estrela","year":"2016","journal-title":"PLoS One"},{"key":"R22-20250430","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1073858407305725","article-title":"TNFalpha: a trigger of autonomic dysfunction.","volume":"14","author":"Hermann","year":"2008","journal-title":"Neuroscientist"},{"key":"R23-20250430","doi-asserted-by":"crossref","first-page":"34800","DOI":"10.1074\/jbc.M111.235473","article-title":"L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin.","volume":"286","author":"Osawa","year":"2011","journal-title":"J Biol Chem"},{"key":"R24-20250430","doi-asserted-by":"crossref","first-page":"eaaf9794","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health.","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"R25-20250430","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.3748\/wjg.v25.i28.3669","article-title":"Importance of fatigue and its measurement in chronic liver disease.","volume":"25","author":"Gerber","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R26-20250430","first-page":"21","article-title":"Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management.","volume":"17","author":"Kosnik","year":"2022","journal-title":"Prz Gastroenterol"},{"key":"R27-20250430","doi-asserted-by":"crossref","first-page":"698","DOI":"10.14336\/AD.2021.0824","article-title":"The role of kynurenine pathway and NAD(+) metabolism in myalgic encephalomyelitis\/chronic fatigue syndrome.","volume":"13","author":"Dehhaghi","year":"2022","journal-title":"Aging Dis"},{"key":"R28-20250430","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbi.2022.07.011","article-title":"C-reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder.","volume":"105","author":"Zheng","year":"2022","journal-title":"Brain Behav Immun"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:38:50Z","timestamp":1746081530000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MEG.0000000000002895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000002895","relation":{},"ISSN":["0954-691X","1473-5687"],"issn-type":[{"value":"0954-691X","type":"print"},{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]}}}